Z_2-gradings of Clifford algebras and multivector structures

Let Cl(V,g) be the real Clifford algebra associated to the real vector space V, endowed with a nondegenerate metric g. In this paper, we study the class of Z_2-gradings of Cl(V,g) which are somehow compatible with the multivector structure of the Grassmann algebra over V. A complete characterization for such Z_2-gradings is obtained by classifying all the even subalgebras coming from them. An expression relating such subalgebras to the usual even part of Cl(V,g) is also obtained. Finally, we employ this framework to define spinor spaces, and to parametrize all the possible signature changes on Cl(V,g) by Z_2-gradings of this algebra.Comment: 10 pages, LaTeX; v2 accepted for publication in J. Phys.

Space weather studies of IONOLAB group

IONOLAB is an interdisciplinary research group dedicated for handling the challenges of near earth environment on communication, positioning and remote sensing systems. IONOLAB group contributes to the space weather studies by developing state-of-the-art analysis and imaging techniques. On the website of IONOLAB group, www.ionolab.org, four unique space weather services, namely, IONOLAB-TEC, IRI-PLAS-2015, IRI-PLAS-MAP and IRI-PLAS-STEC, are provided in a user friendly graphical interface unit. Newly developed algorithm for ionospheric tomography, IONOLAB-CIT, provides not only 3-D electron density but also tracking of ionospheric state with high reliability and fidelity. The algorithm for ray tracing through ionosphere, IONOLAB-RAY, provides a simulation environment in all communication bands. The background ionosphere is generated in voxels where IRI-Plas electron density is used to obtain refractive index. One unique feature is the possible update of ionospheric state by insertion of Total Electron Content (TEC) values into IRI-Plas. Both ordinary and extraordinary paths can be traced with high ray and low ray scenarios for any desired date, time and transmitter location. 2-D regional interpolation and mapping algorithm, IONOLAB-MAP, is another tool of IONOLAB group where automatic TEC maps with Kriging algorithm are generated from GPS network with high spatio-temporal resolution. IONOLAB group continues its studies in all aspects of ionospheric and plasmaspheric signal propagation, imaging and mapping. © 2016 IEEE

Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming.

Based on their ability to regulate immune responses, MSCs are considered to be potential candidates for managing immune-mediated diseases in the context of immune therapy. AT and WJ are considered valuable alternatives for BM as a source of MSCs. A detailed and comparative characterization of the immunological profile of MSCs derived from different sources, as well as an understanding of their responsiveness under certain circumstances, such as inflammation, is required to facilitate efficient and well-designed clinical studies. Flow cytometric analyses revealed clear differences among MSC types concerning the expression of the endothelial (e.g. CD31, CD34, CD144 and CD309) and stromal (e.g. CD90 and CD105) associated markers. Regardless of their source, MSCs did not express any of the known hematopoietic markers. All MSCs were uniformly positive for HLA-ABC and lacked the expression of HLA-DR and the co-stimulatory molecules (e.g. CD40, CD80, CD86, CD134 and CD252) required for full T-cell activation. Tissue-specific MSCs presented a modulated expression of cell adhesion molecules that is important for their cellular interactions. MSCs exhibited several surface (e.g. CD73, HLA-G, HO-1 and CD274) and soluble (e.g. HGF, PGE2 and IGFBP-3) immunoregulatory molecules. According to these immunological profiles, the present work provides evidence that the source from which MSCs are derived is important for the design of MSC-based immunointervention approaches. In light of these observations, we may suggest that WJ-MSCs appear to be the most attractive cell population to use in immune cellular therapy when immunosuppressive action is required.Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tSCOPUS: ar.jinfo:eu-repo/semantics/publishe

Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump : a randomized controlled trial

BACKGROUND: Perioperative corticosteroid use may reduce acute kidney injury. We sought to test whether methylprednisolone reduces the risk of acute kidney injury after cardiac surgery. METHODS: We conducted a prespecified substudy of a randomized controlled trial involving patients undergoing cardiac surgery with cardiopulmonary bypass (2007-2014); patients were recruited from 79 centres in 18 countries. Eligibility criteria included a moderate-to-high risk of perioperative death based on a preoperative score of 6 or greater on the European System for Cardiac Operative Risk Evaluation I. Patients (n = 7286) were randomly assigned (1:1) to receive intravenous methylprednisolone (250 mg at anesthetic induction and 250 mg at initiation of cardiopulmonary bypass) or placebo. Patients, caregivers, data collectors and outcome adjudicators were unaware of the assigned intervention. The primary outcome was postoperative acute kidney injury, defined as an increase in the serum creatinine concentration (from the preoperative value) of 0.3 mg/dL or greater (>= 26.5 mu mol/L) or 50% or greater in the 14-day period after surgery, or use of dialysis within 30 days after surgery. RESULTS: Acute kidney injury occurred in 1479/3647 patients (40.6%) in the methylprednisolone group and in 1426/3639 patients (39.2%) in the placebo group (adjusted relative risk 1.04, 95% confidence interval 0.96 to 1.11). Results were consistent across several definitions of acute kidney injury and in patients with preoperative chronic kidney disease. INTERPRETATION: Intraoperative corticosteroid use did not reduce the risk of acute kidney injury in patients with a moderate-to-high risk of perioperative death who had cardiac surgery with cardiopulmonary bypass. Our results do not support the prophylactic use of steroids during cardiopulmonary bypass surgery